Table 1.
Phase 1 Demographic Data, Laboratory Values and Bleeding Scores
Control (n=38) | Affected (n=20) | p value | |
---|---|---|---|
Male gender (%) | 18 (47) | 2 (10) | 0.006 |
Mean age years (range) | 39 (18 – 72) | 36 (18 – 59) | 0.294 |
Mean VWF:Ag IU/mL (range) | 1.01 (0.65 – 1.46)* | 0.59 (0.47 – 0.93) | <0.001 |
Mean VWF:RCo IU/mL (range) | 0.69 (0.61 – 1.22)* | 0.38 (0.21 – 0.58) | < 0.001 |
Mean FVIII IU/mL (range) | 1.34 (0.71 – 1.49)* | 0.71 (0.47 – 0.93) | < 0.001 |
Blood Group O (%) | 15 (40) | 16 (80) | 0.001 |
Mean Self-BAT BS (range) | 1.2 (0 – 4) | 10 (4 – 17) | < 0.001 |
Mean ISTH-BAT BS (range) | 1.5 (0 – 4) | 11 (5 – 20) | < 0.001 |
VWF:Ag = VWF antigen, VWF:RCo = VWF ristocetin cofactor activity, FVIII = Factor VIII, Chi-square analysis was performed for categorical variables, and Mann-Whitney for continuous variables.
Data from 2 control subjects were excluded due to sample thaw prior to analysis.